1. Introduction
One of the numerous tests required for any new medical device implant is performance testing, also known as bench testing [
1,
2]. This test is essential to demonstrate that the device can withstand the mechanical forces in the area of implantation. As part of developing a new ocular implant designed for retinal detachments involving the posterior pole of the eye, we conducted a performance (bench) test [
3,
4].
Posterior pole detachments are common in eyes with high myopia, where a posterior staphyloma (defined as an abnormal outward protrusion and thinning of the scleral wall) leads to localized bulging of the posterior globe (
Figure 1) [
5,
6,
7,
8], necessitating indentation in this area to correct the underlying pathology. This clinical scenario remains particularly challenging, as highlighted in recent reviews on the management of myopic maculopathy [
9]. Without proper indentation, it is extremely difficult, or even impossible, to address the detachment condition effectively [
1,
2,
10,
11,
12,
13,
14,
15]. Pars plana vitrectomy addresses retinal pathology internally by relaxing traction and allowing the retina to be stretched and reattached over a posterior scleral bulge. In contrast, a macular buckle corrects the underlying structural abnormality by externally indenting the posterior sclera, thereby reducing the bulge and allowing the retina to re-approximate and stabilize against it, with or without adjunctive vitrectomy [
8,
9,
12,
14,
15]. Currently, there are limited approved implant options available outside the U.S., and none for this unmet need within the U.S., despite the increasing global prevalence of myopia [
15]. Recent preliminary clinical experiences with titanium macular buckles have also demonstrated feasibility and encouraging outcomes in highly myopic eyes [
16].
The titanium scleral buckle implant (TSBI) analyzed and tested in this study showed potential additional benefits, including substantial correction of high myopia (>8 diopters) while repairing retinal detachment, by pushing the staphyloma bulge inward and maintaining a stable, long-lasting shape correction. The size of the buckle concave plate was carefully selected to fill the critical gap between the eye muscle tendon and the optic nerve end, while being supported at the side of the eye by sutures. The proposed titanium implant has already been used under special circumstances in a limited number of patients across various countries, with the necessary permissions, and all trial cases have remained successful for at least three years.
Such a device is urgently needed in the U.S. to treat retinal detachment (with the additional potential benefit of correcting eyesight), which, if left untreated, can lead to blindness. The implant remains in the research stage for FDA approval, with both FEM and performance testing completed as part of this regulatory process.
2. Methods
We tested 7 units as part of the performance evaluation. The design and positioning of the implant on the eye are illustrated in
Figure 2A. The side view in
Figure 2B shows the plate indenting the posterior pole, and the anterior view in
Figure 2C shows the location of the main anchoring suture. The implant is manufactured from Ti-6Al-4V (Grade 5) titanium and finished with a medical-grade anodized surface to enhance corrosion resistance, wear durability, and long-term stability. The buckle has a uniform thickness of 0.7 mm, with a main body width of 3.5 mm and fork edges measuring 0.8 mm in width. The overall length of the implant is 21.8 mm from tip to tip. Surface profilometry of representative planar regions of the titanium buckle showed consistent sub-micron roughness, with mean areal roughness values (Sa) in the range of approximately 0.31–0.47 µm, indicating a smooth, well-finished medical device surface. The total mass of the titanium buckle is approximately 0.28 g, corresponding to less than 4% of the average mass of the human eye. The titanium buckle has a thin, low-profile geometry and is positioned beneath Tenon’s capsule, allowing the implant to move synchronously with the globe during ocular motion. Its minimal bulk and targeted posterior placement avoid contact with the extraocular muscles and excessive occupation of the orbital space, which may be encountered with bulkier designs based on soft viscoelastic materials. The implant is sutured approximately 17–20 mm from the limbus, with the primary suture stabilizing the body of the implant at its pivot point. The curved section in the posterior part, featuring a φ 7 mm diameter concave plate, provides the necessary indentation to address the bulging in the posterior pole of the eye. This bulging, the staphyloma, is the underlying cause of retinal detachment, as the retina cannot stretch sufficiently to fit the shape of the eye, leading to separation from the retinal pigment epithelium and subsequent loss of function. Various vitrectomy techniques attempting to reposition the retina from the inside have been ineffective or unnatural.
When the implant is secured to the eye with the primary suture, the plate and double-horn sections are pushed outward due to intraocular pressure. Since the implant cannot be tested on an eye with changing pressure, we developed a representative analytical model to test the implant’s bending resistance to forces applied in a similar manner. The force interaction between the eye and implant is shown in
Figure 3, and our test model representation is shown in
Figure 4.
3. Summary of Mechanical Design Evaluation and Testing
To ensure the long-term safety and functional stability of the TSBI, a multi-stage mechanical evaluation was conducted, combining closed-form analytical estimates, laboratory load testing, and finite element modeling (FEM). This approach was intended not only to confirm that the implant can withstand physiological loading conditions but also to demonstrate that it does so with a substantial margin of safety over its intended lifetime, without viscoelastic time-dependent deformation and with only negligible deformation under ocular geometry changes and intraocular pressure variations. Detailed engineering calculations, experimental procedures, and numerical modeling results are provided in the
Appendix A, while the present section summarizes the key mechanical findings for a general readership.
First, the bending capacity of the TSBI was evaluated in both transverse and longitudinal directions using a calibrated mechanical test setup. Controlled load tests were performed experimentally to obtain and validate analytical capacity predictions. The implant was subjected to progressively increasing loads far exceeding those expected in vivo. Mechanical testing showed that the TSBI exhibited an initial transverse stiffness of approximately 45 N/mm (with a nonlinear unloading stiffness of ~19 N/mm) and a longitudinal stiffness of ~9 N/mm. Using the validated analytical capacity checks, the pressure required to initiate yielding was estimated at approximately 3958 mmHg, corresponding to a titanium yield strength of 912.9 MPa (ultimate strength 944.9 MPa). By proportional scaling, the predicted implant stress under extreme transient intraocular pressures of 100–150 mmHg is on the order of ~23–35 MPa, representing only ~2.5–3.8% of the yield strength. These results support the conclusion that the implant remains fully elastic throughout physiological loading and retains a very large margin relative to yielding and fatigue-relevant stress levels.
Simplified engineering calculations were used to estimate the magnitude of forces exerted by the eye on the implant under both normal and extreme intraocular pressure conditions. These calculations showed that forces generated by clinically relevant pressure changes are relatively small, on the order of tenths of a Newton. When these forces were compared with the measured stiffness of the titanium implant, the resulting deformations were found to be on the micrometer scale, several orders of magnitude smaller than what would be required to alter implant geometry or compromise posterior pole support. Using the experimentally measured stiffness values (≈45 N/mm transverse and ≈9 N/mm longitudinal) and the eye-induced force estimate (~0.10 N per ~20 mmHg), the expected implant deflection under extreme transient pressures remains very small, on the order of ~11–17 µm at 100–150 mmHg in the transverse direction. These micrometer-scale deformations are mechanically negligible relative to implant geometry and remain well within the elastic response range based on both the experimental and analytical results.
Nonlinear finite element simulations were used to evaluate the global mechanical behavior of the implant when interacting with the curved geometry of the eye. These simulations enabled spatial assessment of stress and deformation patterns along the implant, identifying the most highly loaded regions and confirming that stress concentrations remained below 2 MPa and well within safe limits when compared with the material capacity exceeding 900 MPa. Importantly, the simulations demonstrated that the implant behaves as a rigid, shape-stable structure under physiological loading, maintaining posterior pole indentation without time-dependent deformation, which represents an advantage over conventional softer implants.
The FEM results were also used to estimate stress concentrations within the scleral tissue. The contact interface between the TSBI and sclera was modeled using discrete contact elements. While general pressure distributions could be estimated using FEM, a detailed assessment of implant edge geometry was conducted using electron microscope imaging (EMI) and supplementary analytical calculations (
Appendix A.6). These analyses showed that the smoothly rounded and polished implant edges result in scleral stress levels with safety factors ranging from approximately 21 to 39. Given the reported scleral tensile capacity of approximately 1000–4000 kPa, the calculated stresses remain below 50 kPa and are well within safe limits.
Together, these complementary analyses demonstrate that the selected implant thickness and geometry provide a robust mechanical design with safety margins exceeding one to two orders of magnitude relative to eye-induced loads. By combining conservative analytical estimates, experimental validation, EMI-based edge assessment, and computational modeling, this study confirms that the titanium scleral buckle implant can reliably maintain its intended shape and function over long-term implantation without risk of mechanical failure or loss of posterior support.
4. Results
The bending capacity and stiffness of the TSBI were investigated through a series of experimental tests and analytical calculations. The study aimed to evaluate the structural performance of the TSBI under bending conditions simulating its application in ocular surgery and investigate if its strength and stiffness are adequate. The following key findings were observed.
4.1. Experimental Findings
The experimental setup was specifically designed to measure the bending response of the TSBI in both longitudinal and transverse direction loading orientations. The longitudinal orientation tests experienced stability issues, which were resolved using the transverse direction loading setup for linear range and plastic capacity using destructive testing. The results from these tests showed the following.
Light Weight, High Strength, and Linear Elastic Behavior: The TSBIs exhibited linear elastic behavior up to approximately 40 N in the longitudinal orientation configuration, corresponding to a stress of 923.5 MPa and outperforming the yield strain limit of 912.9 MPa from direct tension tests. The initial stiffness, recorded as 45 N/mm (
Figure A4A), indicates robust resistance to deformation under expected loads. Given that the forces acting on the TSBI are expected to be around 0.10262 N for a 20 mmHg pressure change, the resulting deformation of approximately 2.3 microns (about 0.0023 mm) is negligibly small, suggesting that changes in internal eye pressure will not compromise the focal length correction, a behavior that may offer mechanical advantages over softer buckle materials. Not only the strength but also the high stiffness of the TSBI is crucial for maintaining its structural integrity and performance as an ocular implant, providing adequate rigidity without excessive deformation during both implantation and postoperative stages.
Nonlinear and Plastic Behavior: Brittle behavior, often seen in high-strength materials, is undesirable for implants. Beyond the linear range, the TSBI exhibited geometric nonlinearity, followed by a highly desirable plastic behavior. The plastic capacity is reached approximately at 65 N, and the formation of a plastic hinge maintained the force around 70 N with significant, controlled plastic deformations (
Figure A4A). This performance demonstrates the TSBI’s ability to withstand forces far exceeding those expected in clinical conditions, without experiencing catastrophic or brittle failure. Considering the spread of the supports during testing, it can be concluded that the TSBI has a reserved capacity roughly double the linear range, extending beyond the 40 N range observed in testing. Furthermore, metals do not exhibit time-dependent behavior, such as creep or viscoelastic deformations, that may be faced by silicone and rubber-based materials [
17,
18]. This phenomenon may be further aggravated by the fact that stresses would be much closer to the material capacity in the case of silicon buckles.
Stability Issues in Longitudinal Testing: The instability observed in the longitudinal orientation during laboratory testing is not expected to occur in clinical applications, as it was a limitation specific to the testing system. The bending capacity of the TSBI was successfully evaluated using the transverse-direction load testing.
4.2. Analytical Calculations
An analytical approach was used to predict the TSBI’s behavior under simulated ocular loading conditions. These calculations provided a theoretical benchmark against which experimental results were compared. The theoretical analysis confirmed the high strength of Ti-6Al-4V (Grade 5)-based TSBIs, with a calculated bending capacity far exceeding the forces anticipated in clinical settings. Analytical calculations and experimental results demonstrated that the TSBI is approximately two hundred times stronger than the forces generated by a typical internal eye pressure increase of 20 mmHg. Even under extremely high intraocular pressure (IOP) of 100 mmHg, the TSBI provides a safety margin of more than 39.5 times, indicating a highly conservative design. This exceptional capacity, combined with its stiffness and biocompatibility, makes the TSBI an ideal system for ocular implants.
4.3. Comparison of Results
Hand calculations and FEM simulations showed consistent results in terms of the very large safety margin of the TSBI. Analytical calculations predicted maximum implant stresses around 4.84 MPa, whereas FEM localized them in the range of 1.8–2.2 MPa near the fork region. Both values are well below the yielding strength of titanium, confirming the structural robustness of the implant. For the scleral tissue, uniform stress of about 16.5–17.8 kPa is increased to near 35 kPa around the fork region. This higher value is mainly a local stress concentration, which may partly arise from numerical modeling since the sutures were represented as being tied to a single node. In reality, with multiple stitches distributed along the scleral surface, stresses would be more evenly shared and, therefore, conservatively smaller than 35 kPa.
The large overstrength of the TSBI is not only beneficial for providing a wide safety margin but also essential for maintaining the implant shape consistency under varying intraocular pressures. Compared with metallic components, softer silicone-based elastomers may exhibit time-dependent deformation (e.g., creep or tension-bending set) under sustained loading, depending on formulation and loading history [
19,
20]. In our analyses, the titanium buckle maintained its geometry and provided stable indentation, especially considering consistent support in posterior pole detachments. Even under conservative assumptions, the FEM and analytical results confirm that the TSBI operates safely and effectively, offering advantages over conventional materials in challenging clinical scenarios.
5. Discussion
Although titanium is a strong material and an implant made from it would likely withstand the forces exerted by the eyeball and surrounding soft tissue, it was necessary to scientifically demonstrate and prove its strength through mechanical testing. The conducted tests not only provide confidence to the manufacturer and ensure patient safety but are also a critical requirement for the FDA review process.
We aimed to develop a scleral titanium scleral buckle implant (TSBI) capable of providing stable indentation at the posterior pole of the eye [
1,
2]. Conventional scleral buckling systems currently approved for clinical use are predominantly based on elastomeric materials [
10,
21], consistent with traditional scleral indentation techniques described in classical scleral buckling surgical literature [
22], and they were historically designed for equatorial support. The mechanical compliance and time-dependent deformation characteristics of such materials can impose design constraints when extended geometries or long-term shape retention are required for posterior pole indentation.
Medical-grade titanium, with its high stiffness, negligible time-dependent deformation, established biocompatibility, and decades of successful use in other implantable applications, was, therefore, identified as a suitable alternative material to expand the mechanical design envelope for posterior pole support [
23,
24,
25,
26]. The naturally forming oxide layer on titanium provides corrosion resistance and supports a favorable biological response, a combination central to its well-established long-term biocompatibility [
27].
Our design enables the titanium implant to be sutured easily to the equatorial portion of the eye using anatomical locations commonly employed in scleral buckling procedures, while extending to the posterior pole to provide the necessary indentation [
1,
2,
9]. The intuitive design of the titanium implant will allow retina specialists to place it with ease, as the surgical technique closely mirrors that used for common, softer elastomeric buckles.
Recent case reports have demonstrated successful closure of myopic macular holes using titanium buckles alone, highlighting their potential effectiveness in clinical practice [
28]. Early clinical feasibility of the titanium scleral buckle has also been reported by the same surgical group in a published case series involving four highly myopic eyes with posterior pole retinal detachment, three of which were associated with myopic maculoschisis [
3]. In that series, the device was used either in combination with pars plana vitrectomy or as a standalone macular buckle, with successful anatomical reattachment and resolution of maculoschisis or macular hole where present. During ongoing follow-up, no device-related complications, including buckle migration, erosion, infection, or loss of posterior indentation, have been observed. In the two eyes with pre- and postoperative measurements, the titanium macular buckle shortened axial length by approximately 2.5–3.0 mm and reduced high myopia from −13.50 to −1.50 D in one case and from −11.25 to −4.00 D in the other. These observations suggest a secondary, anatomically driven refractive effect in highly myopic eyes. Additional studies are required to determine whether this device, by reducing axial length while maintaining posterior pole shape, might also serve as a refractive treatment in this patient group [
3].
From a clinical handling perspective, the titanium scleral buckle implant was designed with a thin, low-profile geometry and fixed curvature to facilitate controlled positioning at the posterior pole. The primary fixation suture is placed over the body of the implant approximately 17–20 mm posterior to the limbus, with a secondary suture placed through the central hole near the limbus to ensure positional stability. In most cases, two sutures are sufficient for secure fixation, although surgeons may elect to use all three fixation holes based on intraoperative judgment. Because the implant is placed beneath Tenon’s capsule, it avoids direct interaction with extraocular muscles and minimizes the risk of interference with ocular motility. In early clinical experience, no postoperative ocular motility disturbance or diplopia has been reported, an observation that is consistent with the implant’s thin geometry, posterior localization, and limited soft-tissue interaction.
The detailed engineering work presented here was necessary to scientifically demonstrate that the selected implant thickness could withstand all anticipated mechanical demands without permanent deformation, ensuring long-term shape stability. Based on analytical calculations, the expected eye-induced force is on the order of 0.10 N, which, when combined with the measured stiffness of the implant, results in micrometer-scale deformations that are mechanically negligible. The resulting stress levels (<2 MPa) remain far below both the elastic limit and the fatigue endurance threshold of the titanium alloy, and the loading conditions are quasi-static rather than cyclic in nature. Under these conditions, neither plastic deformation nor fatigue-related damage accumulation is expected. The absence of time-dependent deformation in titanium represents a material-level advantage when compared with viscoelastic buckle materials, particularly in applications where long-term geometric stability is required.
We developed models to simulate the forces exerted on various sections of the implant and performed rigorous mechanical testing using precise scientific methods. As shown in the
Section 4, the implant’s weakest point was found to be at least 197.9 times stronger than the 20 mmHg pressure change generated forces by the eye in the linear range (39.6 times stronger compared to 100 mmHg and 26.4 times stronger compared to 150 mmHg internal eye pressure).
This study has demonstrated that titanium not only performs mechanically as an ideal material but also maintains its clinical function without deforming over the patient’s lifetime. Moreover, this research exemplifies an ideal collaboration between medical and engineering disciplines, showing how academic partnerships can drive innovative solutions. Our methods, including simulation and cross-disciplinary collaboration, provide a valuable framework for future implant design and testing.
6. Conclusions
Based on the extensive testing and analysis conducted in this study, the titanium scleral buckle implant (TSBI) is proven to be exceptionally strong, rigid, and effective. The implant’s strength and stiffness, as demonstrated by the experimental tests and extrapolated for high-pressure evaluations, ensure that it maintains its shape and function, even under extreme conditions. The TSBI can withstand internal eye pressures up to approximately 3957 mmHg (linear range and about twice in the nonlinear range), which is 26.4 times higher than the maximum temporarily elevated pressure of 150 mmHg, without experiencing deformation greater than ~17 µm. In contrast to softer elastomeric buckle materials, which may exhibit time-dependent deformation under sustained loading depending on formulation and loading history [
19,
20], the TSBI can be securely positioned with fewer sutures and maintains its original shape, providing consistent indentation for retinal detachment treatment. Additionally, the TSBI’s have approximately two times the reserved capacity beyond their linear range, far exceeding forces expected in clinical settings and further reinforcing their reliability and safety. Both analytical calculations and FEM simulations consistently demonstrated that the TSBI operates with a very large safety margin. The numerical results also confirmed that the implant retains its shape under physiological loading, an advantage over softer polymeric buckles, which may deform in similar conditions. This combined analytical and computational evidence reinforces the safety and effectiveness of the TSBI in the treatment of posterior pole retinal detachment.
Beyond confirming the very large safety margin, the FEM provided a visual and quantitative assessment of how the TSBI engages with the posterior pole and surrounding scleral regions. This computational approach demonstrated that the titanium implant retains its geometry and delivers stable indentation. More broadly, this study illustrates how structural engineering methods can be used to simulate surgical procedures at early stages of medical device development, when clinical testing is not yet feasible.
Although full clinical adoption awaits regulatory approval, early controlled clinical tests outside the USA have been successfully applied and monitored over three years, providing final validation of this extensive and collaborative study. Early clinical experience with the titanium scleral buckle demonstrates feasibility in highly myopic eyes with posterior pole retinal detachment. Larger, systematic studies will be required to determine whether titanium macular buckling may have a broader role in refractive modulation in addition to posterior pole support.
More recently, a multicenter peer-reviewed clinical study reporting outcomes in 11 eyes treated with a titanium macular buckle has been published [
16], reporting partial or complete anatomical resolution in all cases and improvement in best-corrected visual acuity in the majority of patients. In addition, when combined with unpublished clinical experience from the same surgical group and collaborating centers, a total of 16 cases have been performed to date without observed motility-related complications.
The treated patients continue to be followed by the operating surgeons, with no device-related complications, reinforcing the mechanical performance, stability, and safety margins demonstrated by the analytical, experimental, and computational investigations presented in this study.